Gonzalez David Angulo - 04 Feb 2022 Form 4 Insider Report for SCYNEXIS INC (SCYX)

Role
Chief Medical Officer
Signature
/s/ Robert F. Joyce Jr., by Power of Attorney
Issuer symbol
SCYX
Transactions as of
04 Feb 2022
Net transactions value
$0
Form type
4
Filing time
08 Feb 2022, 15:11:09 UTC
Next filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCYX Common Stock Award $0 +51,100 +214% $0.000000 74,981 04 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCYX Stock Option (Right to Buy) Award $0 +85,000 $0.000000 85,000 04 Feb 2022 Common Stock 85,000 $4.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant.
F2 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.